Suzanne M Gilboa

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. Gilboa S, Devine O, Kucik J, Oster M, Riehle Colarusso T, Nembhard W, et al. Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010. Circulation. 2016;134:101-9 pubmed publisher
    ....
  2. Gilboa S, Salemi J, Nembhard W, Fixler D, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010;122:2254-63 pubmed publisher
    ..A large proportion of CHD-related mortality occurred during infancy, although significant CHD mortality occurred during adulthood, indicating the need for adult CHD specialty management. ..
  3. Gilboa S, Ailes E, Rai R, Anderson J, Honein M. Antihistamines and birth defects: a systematic review of the literature. Expert Opin Drug Saf. 2014;13:1667-98 pubmed publisher
    ..Selected antihistamines have been very well studied (e.g., loratadine); others, especially H2-receptor antagonists, require additional study before an assessment of safety with respect to birth defect risk could be made. ..
  4. Gilboa S, Desrosiers T, Lawson C, Lupo P, Riehle Colarusso T, Stewart P, et al. Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002. Occup Environ Med. 2012;69:628-35 pubmed publisher
    ..1, 95% CI 1.1 to 3.8). The authors found evidence of associations between occupational exposure to solvents and several types of CHDs. These results should be interpreted in light of the potential for misclassification of exposure. ..

Detail Information

Publications4

  1. Gilboa S, Devine O, Kucik J, Oster M, Riehle Colarusso T, Nembhard W, et al. Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010. Circulation. 2016;134:101-9 pubmed publisher
    ....
  2. Gilboa S, Salemi J, Nembhard W, Fixler D, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010;122:2254-63 pubmed publisher
    ..A large proportion of CHD-related mortality occurred during infancy, although significant CHD mortality occurred during adulthood, indicating the need for adult CHD specialty management. ..
  3. Gilboa S, Ailes E, Rai R, Anderson J, Honein M. Antihistamines and birth defects: a systematic review of the literature. Expert Opin Drug Saf. 2014;13:1667-98 pubmed publisher
    ..Selected antihistamines have been very well studied (e.g., loratadine); others, especially H2-receptor antagonists, require additional study before an assessment of safety with respect to birth defect risk could be made. ..
  4. Gilboa S, Desrosiers T, Lawson C, Lupo P, Riehle Colarusso T, Stewart P, et al. Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002. Occup Environ Med. 2012;69:628-35 pubmed publisher
    ..1, 95% CI 1.1 to 3.8). The authors found evidence of associations between occupational exposure to solvents and several types of CHDs. These results should be interpreted in light of the potential for misclassification of exposure. ..